Page 1 of Clinical Trials for Advanced HCC, 300 Total Matches
- 1CompletedLast Updated: February 3, 2009Condition(s): Advanced HCC
- 2RecruitingLast Updated: April 13, 2011Condition(s): Hepatocellular Carcinoma
- 3CompletedLast Updated: July 12, 2011Condition(s): Advanced Hepatocellular Carcinoma
- 4CompletedLast Updated: November 21, 2005Condition(s): Hepatocellular Carcinoma
- 5RecruitingLast Updated: August 3, 2011Condition(s): Sorafenib is the Present Standard Treatment for Advanced HCC; More Active Treatments Were Used in Clinical Practice; Whether Active Treatments Could Give Survival Benefit?
- 6Not yet recruitingLast Updated: March 23, 2011Condition(s): Hepatocellular Carcinoma
- 7Active, not recruitingLast Updated: April 30, 2012Condition(s): Hepato Cellular Carcinoma (HCC)
- 8RecruitingLast Updated: February 24, 2010Condition(s): Hepatocellular Carcinoma
- 9CompletedLast Updated: October 13, 2011Condition(s): Hepatocellular Carcinoma
- 10RecruitingLast Updated: February 4, 2011Condition(s): Hepatocellular Carcinoma; Liver Metastases
- 11RecruitingLast Updated: June 14, 2011Condition(s): Advanced Hepatocellular Carcinoma; Carcinoma; Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms
- 12TerminatedLast Updated: December 21, 2011Condition(s): Advanced Hepatocellular Carcinoma (HCC)
- 13TerminatedLast Updated: August 25, 2008Condition(s): Hepatocellular Carcinoma
- 14RecruitingLast Updated: January 11, 2010Condition(s): Hepatocellular Carcinoma
- 15RecruitingLast Updated: April 2, 2012Condition(s): Advanced Solid Malignancies; Child-Pugh A to B7 Advanced Hepatocellular Carcinoma; Solid Cancer Refractory to Standard Therapies; Liver Cancer Refractory to Standard Therapies With Mild and Moderate Liver Function
- 16Not yet recruitingLast Updated: December 20, 2011Condition(s): Kidney Cancer; Liver Cancer
- 17RecruitingLast Updated: February 13, 2009Condition(s): Hepatocellular Carcinoma
- 18RecruitingLast Updated: May 21, 2012Condition(s): Hepatocellular Carinoma; Liver Cancer; HCC
- 19CompletedLast Updated: September 1, 2010Condition(s): Carcinoma, Hepatocellular
- 20CompletedRadioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaLast Updated: June 30, 2011Condition(s): Hepatocellular Carcinoma; Liver Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Advanced+HCC
